| 國立交通大學 |
2019-04-02T05:58:20Z |
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
|
Liao, Wei-Siang; Ho, Yu; Lin, Yu-Wei; Raj, Emmanuel Naveen; Liu, Kuang-Kai; Chen, Chinpiao; Zhou, Xiao-Zhen; Lu, Kun-Ping; Chao, Jui-I |
| 中國醫藥大學 |
2015-10 |
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
|
(Hsieh YH);(Hsieh SC);李建興(Chien-Hsin Lee);(Yang SF);(Cheng CW);(Tang MJ);(Chia-Liang Lin);(Lin CL);鄒瑞煌(Ruey-Hwang Chou)* |
| 國立成功大學 |
2019-12-17 |
Targeting Endogenous Adduction Level of Serum Albumin by Parallel Reaction Monitoring via Standard Additions and Intact Protein Measurement: Biological Dosimetry of Catechol Estrogens
|
Huang;Yu-Shan;Lin;Yu-Min;Chen;Hsin;Wu;Chih-Hsing;Syu;Chong-Hua;Huang;Ting-En;Do;Quynh-Trang;Chen;Shu-Hui |
| 臺大學術典藏 |
2008 |
Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih; Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih |
| 國立臺灣大學 |
2008 |
Targeting Endoplasmic Reticulum Stress and Akt with OSU-03012 and Gefitinib or Erlotinib to Overcome Resistance to Epidermal Growth Factor Receptor Inhibitors
|
Wang, Yu-Chieh; Kulp, Samuel K.; Wang, Dasheng; Yang, Chih-Cheng; Sargeant, Aaron M.; Hung, Jui-Hsiang; Kashida, Yoko; Yamaguchi, Mamoru; Chang, Geen-Dong; Chen, Ching-Shih |
| 臺大學術典藏 |
2018-09-10T08:29:51Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin, S.-L. and Chang, F.-C. and Schrimpf, C. and Chen, Y.-T. and Wu, C.-F. and Wu, V.-C. and Chiang, W.-C. and Kuhnert, F. and Kuo, C.J. and Chen, Y.-M. and Wu, K.-D. and Tsai, T.-J. and Duffield, J.S.; VIN-CENT WU; SHUEI-LIONG LIN; TUN-JUN TSAI; WEN-CHIH CHIANG; YUNG-MING CHEN |
| 臺大學術典藏 |
2020-09-28T07:05:02Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Duffield J.S.; Tsai T.-J.; Wu K.-D.; Chen Y.-M.; Kuo C.J.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Chiang W.-C.; Kuhnert F. |
| 臺大學術典藏 |
2011 |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Yung-Ming Chen;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; YUNG-MING CHEN; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2011 |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Schrimpf C.; Chang F.-C.; Lin S.-L.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; TUN-JUN TSAI; Duffield J.S. |
| 臺大學術典藏 |
2020-12-24T08:38:29Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
WEN-CHIH CHIANG; Wu V.-C.; Chen Y.-T.; Wu C.-F.; Schrimpf C.; Chang F.-C.; Lin S.-L.; Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Wen-Chih Chiang;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Duffield J.S.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-23T02:58:02Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Tsai T.-J.; Wu K.-D.; Chen Y.-M.; Kuo C.J.; Kuhnert F.; Chiang W.-C.; Lin S.-L.;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Vin-Cent Wu;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; VIN-CENT WU; Duffield J.S. |
| 臺大學術典藏 |
2021-08-23T03:44:00Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; FAN-CHI CHANG; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-08-23T23:47:26Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; Chang F.-C.; Schrimpf C.; YI-TING CHEN; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-11-30T04:54:30Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Lin S.-L.; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; VIN-CENT WU; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 臺大學術典藏 |
2021-01-12T03:32:22Z |
Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis
|
Shuei-Liong Lin;Chang F.-C.;Schrimpf C.;Chen Y.-T.;Wu C.-F.;Wu V.-C.;Chiang W.-C.;Kuhnert F.;Kuo C.J.;Chen Y.-M.;Wu K.-D.;Tsai T.-J.;Duffield J.S.; SHUEI-LIONG LIN; Chang F.-C.; Schrimpf C.; Chen Y.-T.; Wu C.-F.; Wu V.-C.; Chiang W.-C.; Kuhnert F.; Kuo C.J.; Chen Y.-M.; Wu K.-D.; Tsai T.-J.; Duffield J.S. |
| 國立臺灣大學 |
2011 |
Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple- Negative Breast Cancer by a Novel Adenosine Monophosphate-Activated Protein Kinase (Ampk) Activator
|
顧記華; 楊小青; 陳慶士; GUH, JIH-HWA; YANG, HSIAO-CHING; CHEN, CHING-SHIH |
| 臺大學術典藏 |
2021-06-02T05:43:48Z |
Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator
|
Lee K.-H.; Hsu E.-C.; JIH-HWA GUH; Yang H.-C.; Wang D.; Kulp S.K.; Shapiro C.L.; Chen C.-S. |
| 臺大學術典藏 |
2021-06-04T03:09:10Z |
Targeting ENT1 and adenosine tone for the treatment of Huntington's disease
|
Kao Y.-H.;Lin M.-S.;Chen C.-M.;Wu Y.-R.;Chen H.-M.;Lai H.-L.;Chern Y.;Chun-Jung Lin; Kao Y.-H.; Lin M.-S.; Chen C.-M.; Wu Y.-R.; Chen H.-M.; Lai H.-L.; Chern Y.; CHUN-JUNG LIN |
| 臺北醫學大學 |
2006 |
Targeting epidermal growth factor receptor in lung cancer: Perspective from the Asia–Pacific region
|
劉興璟; Liu HE; Lim KH; Huang MJ; Huang BS |
| 國立臺灣大學 |
2013 |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai, Yu-Chieh; Yeh, Chih-Hsien; Tzen, Kai-Yuan; Ho, Pei-Yin; Tuan, Tsung-Fan; Pu, Yeong-Shiau; Cheng, Ann-Lii; Cheng, Jason Chia-Hsien; 蒲永孝; 曾凱元; 鄭安理; 成佳憲; 蔡育傑; 何蓓茵 |
| 臺大學術典藏 |
2021-02-02T00:46:32Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Yu-Chieh Tsai;Yeh C.-H.;Tzen K.-Y.;Ho P.-Y.;Tuan T.-F.;Pu Y.-S.;Cheng A.-L.;Cheng J.C.-H.; YU-CHIEH TSAI; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:49Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; ANN-LII CHENG; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-18T05:59:06Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; KAI-YUAN TZEN; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-09-16T03:41:20Z |
Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling
|
Hung C.-T.; Su T.-H.; Chen Y.-T.; Wu Y.-F.; Chen Y.-T.; SUNG-JAN LIN; Lin S.-L.; Yang K.-C. |
